J&J set to begin India trial of its single-shot vaccine yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
FILE PHOTO: Johnson & Johnson COVID-19 vaccine is administered in Bay Shore, NY
BENGALURU (Reuters) -Johnson & Johnson has told Indian regulators that it will soon begin clinical trials of its single-shot COVID-19 vaccine in the country, the Indian Express newspaper reported on Friday.
The U.S. drugs and healthcare giant has sent a letter to India’s Central Drugs Standard Control Organisation (CDSCO) saying it would “very shortly apply for permission to conduct clinical bridging trials in India,” according to the report. (https://bityl.co/6Jif)
The report comes as many vaccination centres in India grapple with a shortage of vaccine supplies as the country of 1.3 billion is battling a second wave of COVID-19 infections that has eclipsed the first. India’s government, however, has repeatedly said there is no shortage of shots.
Reuters/Bengaluru
Reuters
The US drugs and healthcare giant’s vaccine is currently approved for use in the United States, the European Union and other nations including Thailand and South Africa.
Johnson & Johnson is in talks with India’s government to begin a clinical trial of its single-dose Covid-19 vaccine in the country, the company said on Friday.
The US drugs and healthcare giant’s vaccine is currently approved for use in the United States, the European Union and other nations including Thailand and South Africa.
The news comes as some parts of India face a shortage of vaccine supplies just as the country of 1.3 billion battles a second wave of Covid-19 infections. India’s government, however, has said there is no shortage of shots.
Synopsis
The U.S. drugs and healthcare giant s vaccine is currently approved for use in the United States, the European Union and other nations including Thailand and South Africa.
AFP
Johnson & Johnson is in talks with India s government to begin a clinical trial of its single-dose COVID-19 vaccine in the country, the company said on Friday.
The U.S. drugs and healthcare giant s vaccine is currently approved for use in the United States, the European Union and other nations including Thailand and South Africa.
The news comes as some parts of India face a shortage of vaccine supplies just as the country of 1.3 billion battles a second wave of COVID-19 infections. India s government, however, has said there is no shortage of shots.
2 Min Read
BENGALURU (Reuters) - Johnson & Johnson is in talks with India’s government to begin a clinical trial of its single-dose COVID-19 vaccine in the country, the company said on Friday.
FILE PHOTO: Johnson & Johnson s coronavirus disease (COVID-19) vaccines are seen at Northwell Health s South Shore University Hospital in Bay Shore, New York, U.S., March 3, 2021. REUTERS/Shannon Stapleton/File Photo
The U.S. drugs and healthcare giant’s vaccine is currently approved for use in the United States, the European Union and other nations including Thailand and South Africa.
The news comes as some parts of India face a shortage of vaccine supplies just as the country of 1.3 billion battles a second wave of COVID-19 infections. India’s government, however, has said there is no shortage of shots.